- Home
- RDCM vs PROF Comparison
RDCM vs PROF Comparison
Compare RDCM & PROF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RDCM | PROF |
|---|---|---|
| Founded | 1985 | N/A |
| Country | Israel | Canada |
| Employees | N/A | N/A |
| Industry | Computer peripheral equipment | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 223.0M | 230.4M |
| IPO Year | 1997 | N/A |
Fundamental Metrics
Financial Performance| Metric | RDCM | PROF |
|---|---|---|
| Price | $12.96 | $8.05 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $18.00 | $12.00 |
| AVG Volume (30 Days) | 39.2K | ★ 251.2K |
| Earning Date | 02-11-2026 | 03-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 37.57 | N/A |
| EPS | ★ 0.64 | N/A |
| Revenue | ★ $68,901,000.00 | $14,297,000.00 |
| Revenue This Year | $18.86 | $64.23 |
| Revenue Next Year | $11.39 | $113.06 |
| P/E Ratio | $20.34 | ★ N/A |
| Revenue Growth | 17.27 | ★ 67.94 |
| 52 Week Low | $9.88 | $3.76 |
| 52 Week High | $15.98 | $8.95 |
Technical Indicators
Market Signals| Indicator | RDCM | PROF |
|---|---|---|
| Relative Strength Index (RSI) | 40.70 | 56.12 |
| Support Level | $12.83 | $8.12 |
| Resistance Level | $13.12 | $8.95 |
| Average True Range (ATR) | 0.32 | 0.49 |
| MACD | -0.04 | 0.01 |
| Stochastic Oscillator | 6.98 | 49.87 |
Price Performance
Historical ComparisonAbout RDCM Radcom Ltd.
Radcom Ltd Ltd is engaged in providing network intelligence, 5G ready cloud-native, network intelligence solutions for telecom operators transitioning to 5G. The company has a network intelligence solution for 5G namely Radcom ACE. Its products consist of Radcom Network Visibility, Radcom Service Assurance, and Radcom Network Insights. It has offices in Israel, the United States, Brazil, and India. Key revenue is derived from sales in North America.
About PROF Profound Medical Corp.
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.